Advertisement

Approach to Patients with Refractory Constipation

  • Kok-Ann Gwee
  • Xiaorong Gong
  • Kewin Tien Ho Siah
Chapter

Abstract

A review of relevant publications revealed that the criteria for defining refractory constipation were ill-defined. Common treatment for constipation includes osmotic, stimulant, and enterokinetic agents. Prucalopride is a new enterokinetic agent that has been shown in clinical trials to produce significant improvements in bowel functions, gastrointestinal symptoms, and quality of life. Patients who fail pharmacological treatment should be referred to specialized centers for physiological laboratory evaluation like transit studies, balloon expulsion, anorectal manometry, and defecography. Potential pathophysiology of refractory constipation include physiological disturbances like pelvic floor dyssynergia and slow transit constipation. Physical defects such as rectocoele and internal prolapse are uncommon. Psychological disturbances have been linked to persistent GI symptoms. Non-pharmacological treatments to consider include biofeedback and behavioral therapy. More studies are needed before surgery can be recommended. There is the possibility that a wider acceptance of the use of laxatives may substantially reduce the number of patients with refractory constipation.

Keywords

Constipation Laxative Biofeedback Psychological Surgery Bowel 

References

  1. 1.
    Gwee KA, Ghoshal UC, Gonlachanvit S, Chua AS, Myung SJ, Rajindrajith S, et al. Primary care management of chronic constipation in Asia: the ANMA chronic constipation tool. J Neurogastroenterol Motil. 2013;19:149–60.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Quigley EM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–28.CrossRefPubMedGoogle Scholar
  3. 3.
    Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358:2344–54.CrossRefPubMedGoogle Scholar
  4. 4.
    Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut. 2009;58:357–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Ke M, Zou D, Yuan Y, et al. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil. 2012;24:999–e541.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol. 2011;9:577–83.CrossRefPubMedGoogle Scholar
  7. 7.
    Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation – follow-up of patients from the pivotal studies. Aliment Pharmacol Ther. 2010;32:1113–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Kerstens R, Vandeplassche L, Dubois D, Wouters L. Response of chronic constipation symptoms to prucalopride treatment and relationship with patient satisfaction. Gut. 2011;60:A159.CrossRefGoogle Scholar
  9. 9.
    Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100:1605–15.CrossRefPubMedGoogle Scholar
  10. 10.
    Gonlachanvit S, Patcharatrakul T. Causes of idiopathic constipation in Thai patients: associations between the causes and constipation symptoms as defined in the Rome II criteria. J Med Assoc Thai. 2004;87 Suppl 2:S22–8.PubMedGoogle Scholar
  11. 11.
    Kim DH, Myung SJ, Yang SK, et al. Clinical parameters for differentiating pelvic floor dyssynergia (PFD) in constipated patients. Korean J Gastroenterol Motil. 2002;8:167–76.Google Scholar
  12. 12.
    Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995;90:1471–5.PubMedGoogle Scholar
  13. 13.
    Lau CW, Heymen S, Alabaz O, Iroatulam AJ, Wexner SD. Prognostic significance of rectocele, intussusception, and abnormal perineal descent in biofeedback treatment for constipated patients with paradoxical puborectalis contraction. Dis Colon Rectum. 2000;43:478–82.CrossRefPubMedGoogle Scholar
  14. 14.
    Boyd C, Abraham S, Kellow J. Psychological features are important predictors of functional gastrointestinal disorders in patients with eating disorders. Scand J Gastroenterol. 2005;40:929–35.CrossRefPubMedGoogle Scholar
  15. 15.
    Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990;113:828–33.CrossRefPubMedGoogle Scholar
  16. 16.
    Arnold RP, Rogers D, Cook DA. Medical problems of adults who were sexually abused in childhood. BMJ. 1990;300:705–8.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bachmann GA, Moeller TP, Benett J. Childhood sexual abuse and the consequences in adult women. Obstet Gynecol. 1988;71:631–42.PubMedGoogle Scholar
  18. 18.
    Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003;98:789–97.CrossRefPubMedGoogle Scholar
  19. 19.
    Mason HJ, Serrano-Ikkos E, Kamm MA. Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation. Am J Gastroenterol. 2002;97:3154–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Bleijenberg G, Kuijpers HC. Treatment of the spastic pelvic floor syndrome with biofeedback. Dis Colon Rectum. 1987;30:108–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Lestar B, Penninckx F, Kerremans R. Biofeedback defaecation training for anismus. Int J Colorectal Dis. 1991;6:202–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130:657–64.CrossRefPubMedGoogle Scholar
  23. 23.
    Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50:428–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5:331–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psychological enquiry. Eur J Gastroenterol Hepatol. 2001;13:39–44.CrossRefPubMedGoogle Scholar
  26. 26.
    Yoshioka K, Keighley MR. Randomized trial comparing anorectal myectomy and controlled anal dilatation for outlet obstruction. Br J Surg. 1987;74:1125–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Pinho M, Yoshioka K, Keighley MR. Long term results of anorectal myectomy for chronic constipation. Br J Surg. 1989;76:1163–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Schouten WR. Severe, longstanding constipation in adults. Indications for surgical treatment. Scand J Gastroenterol Suppl. 1991;188:60–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Kamm MA, Hawley PR, Lennard-Jones JE. Outcome of colectomy for severe idiopathic constipation. Gut. 1988;29:969–73.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Nyam DC, Pemberton JH, Ilstrup DM, Rath DM. Long-term results of surgery for chronic constipation. Dis Colon Rectum. 1997;40:273–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Ghosh S, Papachrysostomou M, Batool M, Eastwood MA. Long-term results of subtotal colectomy and evidence of noncolonic involvement in patients with idiopathic slow-transit constipation. Scand J Gastroenterol. 1996;31:1083–91.CrossRefPubMedGoogle Scholar
  32. 32.
    Bassotti G, Chiarioni G, Germani U, Battaglia E, Vantini I, Morelli A. Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity. Digestion. 1999;60:69–73.CrossRefPubMedGoogle Scholar
  33. 33.
    Herve S, Savoye G, Behbahani A, Leroi AM, Denis P, Ducrotte P. Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil. 2004;16:397–402.CrossRefPubMedGoogle Scholar
  34. 34.
    Kamm MA, van der Sijp JR, Lennard-Jones JE. Observations on the characteristics of stimulated defaecation in severe idiopathic constipation. Int J Colorectal Dis. 1992;7:197–201.CrossRefPubMedGoogle Scholar
  35. 35.
    O’Brien S, Hyman N, Osler T, Rabinowitz T. Sexual abuse: a strong predictor of outcomes after colectomy for slow-transit constipation. Dis Colon Rectum. 2009;52:1844–7.CrossRefPubMedGoogle Scholar
  36. 36.
    FitzHarris GP, Garcia-Aguilar J, Parker SC, Bullard KM, Madoff RD, Goldberg SM, et al. Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum. 2003;46:433–40.CrossRefPubMedGoogle Scholar
  37. 37.
    El-Tawil AM. Persistence of abdominal symptoms after successful surgery for idiopathic slow transit constipation. South Med J. 2002;95:1042–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Zutshi M, Hull TL, Trzcinski R, Arvelakis A, Xu M. Surgery for slow transit constipation: are we helping patients? Int J Colorectal Dis. 2007;22:265–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Zarate N, Knowles CH, Yazaki E, Lunnis PJ, Scott SM. Clinical presentation and patterns of slow transit constipation do not predict coexistent upper gut dysmotility. Dig Dis Sci. 2009;54:122–31.CrossRefPubMedGoogle Scholar
  40. 40.
    Seidl H, Gundling F, Pehl C, Pfeiffer A, Schepp W, Schmidt T. Small bowel motility in functional chronic constipation. Neurogastroenterol Motil. 2009;21:1278–e122.CrossRefPubMedGoogle Scholar
  41. 41.
    Preston DM, Hawley PR, Lennard-Jones JE, Todd IP. Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane’s disease). Br J Surg. 1984;71:547–52.CrossRefPubMedGoogle Scholar
  42. 42.
    Knowles CH, Scott M, Lunniss PJ. Outcome of colectomy for slow transit constipation. Ann Surg. 1999;230:627–38.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Glia A, Akerlund JE, Lindberg G. Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility. Dis Colon Rectum. 2004;47:96–102.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Kok-Ann Gwee
    • 1
  • Xiaorong Gong
    • 2
  • Kewin Tien Ho Siah
    • 3
    • 4
  1. 1.Department of MedicineNational University HospitalSingaporeSingapore
  2. 2.Division of Gastroenterology and HepatologyThe First Affiliated Hospital, Guangzhou Medical UniversityGuangzhouChina
  3. 3.Division of Gastroenterology and HepatologyUniversity Medicine Clinic, National University Hospital, National University Health SystemSingaporeSingapore
  4. 4.Department of MedicineYong Loo Lin School of Medicine, National University of SingaporeSingaporeSingapore

Personalised recommendations